All Stories
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
Defining — And Delivering — the Value in Value-Based Care
For nearly two decades, value-based care has been a hot topic in health care. And for good reason. After all, experts agree that the premise of generating a new care environment that prioritizes…
-
‘You Made My Day:’ DaVita Health Tour Creates Connection and Kidney Health Awareness for Community Members
The 2023 DaVita Health Tour just hit six weeks on the road, reaching thousands of community members with free health screenings and education focused on kidney health. Find out where the DaVita…
-
Making a Difference: DaVita Regional Home Manager Reflects on Her Passion for Helping Dialysis Patients Succeed on a Home Modality
Kimberly Keaveny has held many roles in her 12 years as a DaVita teammate (employee). When she was still a licensed practical nurse (LPN) early in her career, she had the chance to shadow nurses…
-
From Silos to Integrated Systems: Improving Transplantation Access and Outcomes
For many, kidney transplant is the optimal life-saving treatment for end stage kidney disease. Yet the path from diagnosis to transplantation can be extraordinarily long and complex. I saw this…
-
DaVita is Headed to HLTH! Here’s Where You Can Find Us
This year, Javier Rodriguez, CEO of DaVita, will return to HLTH to talk about the role value-based care plays in the future of health care. Also speaking at the conference will be Kenny Gardner,…